| Apr'19 | Apr'18 | Apr'17 | ||||
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net loss | ||||||
-102,303 | -52,727 | -51,968 | ||||
Adjustments to reconcile net loss to cash used in operating activities: | ||||||
Depreciation and amortization | ||||||
5,695 | 5,066 | 3,150 | ||||
Amortization of deferred contract acquisition costs | ||||||
21,374 | 12,731 | 8,417 | ||||
Stock-based compensation expense | ||||||
39,942 | 12,742 | 18,886 | ||||
Deferred income taxes | ||||||
3,621 | -323 | 663 | ||||
Other | ||||||
-69 | -1 | -30 | ||||
Changes in operating assets and liabilities, net of impact of business acquisitions: | ||||||
Accounts receivable, net | ||||||
29,804 | 21,606 | 11,128 | ||||
Deferred contract acquisition costs | ||||||
30,006 | 20,497 | 12,290 | ||||
Prepaid expenses and other current assets | ||||||
18,049 | 6,920 | 3,707 | ||||
Other assets | ||||||
3,292 | 8,502 | -600 | ||||
Accounts payable | ||||||
2,226 | -23 | -241 | ||||
Accrued expenses and other liabilities | ||||||
10,872 | 5,380 | 1,935 | ||||
Accrued compensation and benefits | ||||||
3,842 | 8,045 | 2,595 | ||||
Deferred revenue | ||||||
71,876 | 45,814 | 26,951 | ||||
Net cash used in operating activities | ||||||
-23,937 | -20,819 | -16,107 | ||||
Cash flows from investing activities | ||||||
Purchases of property and equipment | ||||||
3,447 | 2,968 | 843 | ||||
Purchases of short-term investments | ||||||
- | - | 15,000 | ||||
Maturities of short-term investments | ||||||
- | 15,000 | - | ||||
Business acquisitions, net of cash acquired | ||||||
1,986 | 3,702 | 4,488 | ||||
Other | ||||||
2,850 | - | - | ||||
Net cash used in investing activities | ||||||
-8,283 | 8,330 | -20,331 | ||||
Cash flows from financing activities | ||||||
Proceeds from the issuance of redeemable convertible preference shares, net of issuance costs | ||||||
- | - | 57,806 | ||||
Net proceeds from issuance of ordinary shares in initial public offering | ||||||
269,514 | - | - | ||||
Proceeds from issuance of ordinary shares upon exercise of stock options | ||||||
18,552 | 2,337 | 2,086 | ||||
Proceeds from the issuance of ordinary shares related to early exercise of stock options | ||||||
- | 1,566 | - | ||||
Repurchase of ordinary shares | ||||||
- | 344 | 25 | ||||
Repurchase of early exercised options | ||||||
500 | - | - | ||||
Repayment of notes payable | ||||||
106 | 132 | 106 | ||||
Payment of deferred offering costs | ||||||
5,672 | - | 194 | ||||
Net cash provided by financing activities | ||||||
281,788 | 3,427 | 59,761 | ||||
Effect of exchange rate changes on cash, cash equivalents, and restricted cash | ||||||
-897 | 781 | -635 | ||||
Net increase (decrease) in cash, cash equivalents, and restricted cash | ||||||
248,671 | -8,281 | 22,688 | ||||
Supplemental disclosures of cash flow information | ||||||
Cash paid for income taxes | ||||||
3,067 | 3,189 | 1,442 | ||||
Cash paid for interest | ||||||
9 | 14 | 21 | ||||
Supplemental disclosures of non-cash investing and financing information | ||||||
Purchases of property and equipment included in accounts payable and accrued liabilities | ||||||
157 | 6 | 69 | ||||
Vesting of early exercised stock options | ||||||
1,019 | 109 | 109 | ||||
Vesting of shares subject to repurchase | ||||||
449 | - | - | ||||
Deferred offering costs accrued, unpaid | ||||||
- | 242 | - | ||||
Issuance of ordinary shares for business combination | ||||||
- | 12,410 | 5,708 | ||||